Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Nervous SystemDRG 073-cranial-and-peripheral-nerve-disorders-with-mcc
    Ask Trek AI about this page

    Cranial and Peripheral Nerve Disorders with MCC: Inpatient Reimbursement Overview

    DRG 073 encompasses complex cranial and peripheral nerve disorders with a Major Complication or Comorbidity, covering high-acuity conditions and complications that increase hospital resource use. Correct assignment affects inpatient reimbursement under Medicare by reflecting elevated clinical complexity and influencing payment tiers within the Medicare Severity Diagnosis-Related Group framework.

    Customize your policy alerts

    Sign up for drg 073 policy alerts

    Get alerted when payer policies referencing 073 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 073 Overview

    DRG 073 covers hospital inpatient stays for cranial and peripheral nerve disorders when a Major Complication or Comorbidity is present, including complex infections, significant neurological deficits, or major systemic complications related to nerve pathology. This Diagnosis-Related Group captures high-resource cases such as complicated neuritis, severe neuropathies with systemic involvement, and post-operative complications affecting cranial or peripheral nerves. It matters for Medicare payment because the presence of a Major Complication or Comorbidity elevates expected resource use and influences the inpatient reimbursement relative to less complex nerve disorder admissions. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and the associated Medicare Severity Diagnosis-Related Group payment tier.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute procedural and neurosurgical intervention trials: studies assessing safety and short-term outcomes of acute interventions such as surgical decompression, microvascular decompression, or targeted nerve decompression for patients admitted with severe cranial or peripheral nerve disorders complicated by life‑ or function‑threatening deficits. These trials enroll inpatients presenting with acute neurologic decline, refractory pain, or progressive cranial nerve palsies and focus on perioperative morbidity, length of stay, and early neurologic recovery metrics. This research is relevant to providers and payers because it informs decision making about high-cost, high-acuity procedures that drive inpatient resource utilization and risk-adjusted reimbursement under this MCC-bearing DRG.
    • Comparative effectiveness and medical management studies: randomized or pragmatic comparative trials and observational cohorts comparing different medical strategies (for example, aggressive immunomodulatory therapy versus stepwise escalation, or conservative pain management versus interventional pain procedures) for subacute to subchronically ill inpatients with inflammatory or compressive cranial and peripheral nerve disorders. These studies target heterogeneous inpatient populations such as those with Guillain-Barré spectrum illness, severe neuropathies with systemic disease, or cranial neuropathies secondary to infectious or autoimmune causes, aiming to measure functional outcomes at discharge, complication rates, and need for critical care. Findings help clinicians and hospital administrators choose evidence-based inpatient treatment pathways that can reduce complications, shorten length of stay, and optimize costs important for DRG-based reimbursement.
    • Post-discharge outcomes, rehabilitation, and utilization research: prospective cohort studies and health services research tracking readmissions, long-term functional recovery, and post‑acute care needs for patients discharged after hospitalization for cranial and peripheral nerve disorders with major complications. These investigations include stratification by inpatient severity, discharge disposition (home, skilled nursing, inpatient rehab), and outpatient therapy intensity to determine predictors of readmission, durable neurologic improvement, and total episode-of-care costs. This area is critical for payers and providers to plan transitional care models, justify inpatient resource allocation, and design bundle or value-based programs that address downstream costs associated with this high-risk DRG.

    Related Codes

    020-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

    021-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-CC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

    022-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITHOUT-CC-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

    023-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITH-MCC-OR-ANTINEOPLASTIC-IMPLANT-OR-EPILEPSY-WITH-NEUROSTIMULATOR

    Craniotomy with Major Device Implant or Complex CNS DRG 023: Inpatient Reimbursement Overview

    024-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITHOUT-MCC

    Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC: Inpatient Reimbursement Overview

    025-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-MCC

    Craniotomy and Endovascular Intracranial Procedures with MCC: Inpatient Reimbursement Overview

    026-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-CC

    Craniotomy and Endovascular Intracranial Procedures with CC: Inpatient Reimbursement Overview

    027-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITHOUT-CC-MCC

    Craniotomy and Endovascular Intracranial Procedures without CC/MCC: Inpatient Reimbursement Overview

    028-SPINAL-PROCEDURES-WITH-MCC

    Spinal Procedures with MCC: Inpatient Reimbursement Overview

    029-SPINAL-PROCEDURES-WITH-CC-OR-SPINAL-NEUROSTIMULATORS

    Spinal Procedures with CC or Spinal Neurostimulators: Inpatient Reimbursement Overview

    Showing 1–10 of 71

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.